Clinical Trial Update: L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating L-carnitine as an adjunct treatment for septic shock patients with acute kidney injury has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis
• Septic Shock

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Severe Sepsis, Shock, Septic | Phase 3 | Status: TERMINATED